1Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich.
4Swiss Epilepsy Clinic, Klinik Lengg AG, Zurich, Switzerland.
Neurosurg Focus. 2018 Sep;45(3):E5. doi: 10.3171/2018.6.FOCUS18221.
OBJECTIVE Surgery has proven to be the best therapeutic option for drug-refractory cases of focal cortical dysplasia (FCD)-associated epilepsy. Seizure outcome primarily depends on the completeness of resection, rendering the intraoperative FCD identification and delineation particularly important. This study aims to assess the diagnostic yield of intraoperative ultrasound (IOUS) in surgery for FCD-associated drug-refractory epilepsy. METHODS The authors prospectively enrolled 15 consecutive patients with drug-refractory epilepsy who underwent an IOUS-assisted microsurgical resection of a radiologically suspected FCD between January 2013 and July 2016. The findings of IOUS were compared with those of presurgical MRI postprocessing and the sonographic characteristics were analyzed in relation to the histopathological findings. The authors investigated the added value of IOUS in achieving completeness of resection and improving postsurgical seizure outcome. RESULTS The neurosurgeon was able to identify the dysplastic tissue by IOUS in all cases. The visualization of FCD type I was more challenging compared to FCD II and the demarcation of its borders was less clear. Postsurgical MRI showed residual dysplasia in 2 of the 3 patients with FCD type I. In all FCD type II cases, IOUS allowed for a clear intraoperative visualization and demarcation, strongly correlating with presurgical MRI postprocessing. Postsurgical MRI confirmed complete resection in all FCD type II cases. Sonographic features correlated with the histopathological classification of dysplasia (sonographic abnormalities increase continuously in the following order: FCD IA/IB, FCD IC, FCD IIA, FCD IIB). In 1 patient with IOUS features atypical for FCD, histopathological investigation showed nonspecific gliosis. CONCLUSIONS Morphological features of FCD, as identified by IOUS, correlate well with advanced presurgical imaging. The resolution of IOUS was superior to MRI in all FCD types. The appreciation of distinct sonographic features on IOUS allows the intraoperative differentiation between FCD and non-FCD lesions as well as the discrimination of different histological subtypes of FCD. Sonographic demarcation depends on the underlying degree of dysplasia. IOUS allows for more tailored resections by facilitating the delineation of the dysplastic tissue.
手术已被证明是治疗药物难治性局灶性皮质发育不良(FCD)相关性癫痫的最佳治疗选择。癫痫发作的结果主要取决于切除的完整性,这使得术中 FCD 的识别和描绘尤为重要。本研究旨在评估术中超声(IOUS)在 FCD 相关性药物难治性癫痫手术中的诊断效果。
作者前瞻性纳入了 2013 年 1 月至 2016 年 7 月期间 15 例接受 IOUS 辅助的放射学可疑 FCD 显微镜下切除术的药物难治性癫痫患者。将 IOUS 的发现与术前 MRI 后处理的结果进行比较,并分析声像特征与组织病理学发现之间的关系。作者研究了 IOUS 在实现切除完整性和改善术后癫痫发作结果方面的附加价值。
在所有病例中,神经外科医生都能够通过 IOUS 识别出发育不良组织。与 FCD II 相比,FCD I 的可视化更具挑战性,其边界的划定也不那么清晰。术后 MRI 显示 3 例 FCD I 型中有 2 例仍有发育不良残留。在所有 FCD II 型病例中,IOUS 允许术中清晰地可视化和划定边界,与术前 MRI 后处理结果强烈相关。所有 FCD II 型病例的术后 MRI 均证实了完全切除。声像特征与发育不良的组织病理学分类相关(声像异常以下列顺序连续增加:FCD IA/IB、FCD IC、FCD IIA、FCD IIB)。在 1 例 IOUS 表现不典型 FCD 的患者中,组织病理学检查显示非特异性神经胶质增生。
IOUS 识别的 FCD 形态特征与先进的术前成像很好地相关。在所有 FCD 类型中,IOUS 的分辨率均优于 MRI。IOUS 上的不同声像特征有助于术中区分 FCD 和非 FCD 病变,以及区分 FCD 的不同组织学亚型。声像划定取决于潜在的发育不良程度。IOUS 通过促进发育不良组织的描绘,允许更有针对性的切除。